Performance of the APOP-screener for predicting in-hospital mortality in older COVID-19 patients: a retrospective study

Marleen G A M van der Velde*, Merel J van der Aa, Merel H C van Daal, Marjolein N T Kremers, Carolina J P W Keijsers, Sander M J van Kuijk, Harm R Haak

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

BACKGROUND: A variety of prediction models concerning COVID-19 have been proposed since onset of the pandemic, but to this date no gold standard exists. Mortality rates show a sharp increase with advancing age but with the large heterogeneity of this population in terms of comorbidities, vulnerability and disabilities, identifying risk factors is difficult. Therefore, we aimed to research the multidimensional concept of frailty, measured by the Acute Presenting Older Patient (APOP)-screener, as a risk factor for in-hospital mortality in older COVID-19 patients.

METHODS: All consecutive patients of 70 years or older, with a PCR confirmed COVID-19 infection and a completed APOP-score, presenting at the Emergency Department (ED) of the Jeroen Bosch Hospital, the Netherlands, between February 27th 2020 and February 1st 2021 were retrospectively included. We gathered baseline characteristics and scored the CCI and CFS from patient records. The primary outcome was in-hospital mortality.

RESULTS: A total of 292 patients met the inclusion criteria. Approximately half of the patients were considered frail by the APOP or CFS. 127 patients (43.5%) scored frail on the CFS, 158 (54.1%) scored high risk on the APOP-screener. 79 patients (27.1%) died during their hospital admission. The APOP-screener showed a significantly elevated risk of in-hospital mortality when patients scored both high risk of functional and evidence of cognitive impairment (OR 2.24, 95% 1.18-4.25). Significant elevation of in-hospital mortality was found for the high CCI-scores (≥ 5)(OR 1.78, 95% 1.02-3.11), but not for the highest CFS category (5-9, frail) (OR 1.35, 95% 0.75-2.47). The discriminatory performance of the APOP, CFS and CCI were comparable (AUC resp. 0.59 (0.52-0.66), 0.54 (0.46-0.62) and 0.58 (0.51-0.65)).

CONCLUSION: Although the elevated risk for in-hospital mortality found for the most frail patients as scored by the APOP, this instrument has poor discriminatory value. Additionally, the CFS did not show significance in predicting in-hospital mortality and had a poor discriminatory value as well. Therefore, treatment decisions based on frailty or comorbidities alone should be made with caution. Approaching the heterogeneity of the older population by adding frailty as assessed by the APOP-score to existing prediction models may enhance the predictive value of these models.

Original languageEnglish
Article number584
Number of pages10
JournalBMC Geriatrics
Volume22
Issue number1
DOIs
Publication statusPublished - 15 Jul 2022

Keywords

  • COVID-19
  • SARS-Cov2
  • Frailty
  • Predictive
  • Mortality
  • CLINICAL FRAILTY SCALE
  • CORONAVIRUS DISEASE 2019
  • INTERRATER RELIABILITY
  • OUTCOMES
  • COMORBIDITY
  • MULTICENTER
  • SCORE

Fingerprint

Dive into the research topics of 'Performance of the APOP-screener for predicting in-hospital mortality in older COVID-19 patients: a retrospective study'. Together they form a unique fingerprint.

Cite this